$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Oral ciprofloxacin after a short course of intravenous ciprofloxacin in the treatment of spontaneous bacterial peritonitis: results of a multicenter, randomized study

Journal of hepatology : the journal of the European Association for the Study of the Liver, v.33 no.4, 2000년, pp.564 - 569  

Terg, Rubén (Rubé) ,  Cobas, Sergio (n Terg, Unidad de Hepatologí) ,  Fassio, Eduardo (a, Hospital Bonorino Udaondo, Caseros 2061(1264), Buenos Aires, Argentina. Tel: 541 14 306 7362. Fax: 54114 306 2033.) ,  Landeira, Graciela (Unidad de Hepatologia, Hospital Bonorino Udaondo, Buenos Aires, Argentina) ,  Ríos, Beatriz (Hospital A, Posadas, Buenos Aires, Argentina) ,  Vasen, Walter (Hospital A, Posadas, Buenos Aires, Argentina) ,  Abecasis, Raquel (Hospital de Neuqué) ,  Ríos, Héctor (n, Universidad del Salvador, Argentina) ,  Guevara, Mónica (Unidad de Hepatologia, Hospital Bonorino Udaondo, Buenos Aires, Argentina)

Abstract AI-Helper 아이콘AI-Helper

AbstractBackground/Aims: Oral quinolones have been suggested as treatment of cirrhotic patients with uncomplicated spontaneous bacterial peritonitis. To evaluate the efficacy of oral quinolones in all patients with this complication, oral ciprofloxacin after a short course of intraveneous (i.v.) cip...

주제어

참고문헌 (31)

  1. Scand J Gastroenterol Almdal 22 295 1987 10.3109/00365528709078594 Spontaneous bacterial peritonitis in cirrhosis: incidence, diagnosis and prognosis 

  2. Gastroenterol Clin North Am Garcia Tsao 21 257 1992 10.1016/S0889-8553(21)00617-8 Spontaneous bacterial peritonitis 

  3. Hepatology Pinzello 3 545 1983 Spontaneous bacterial peritonitis: a prospective investigation in predominantly nonalcoholic cirrhotic patients 

  4. J Hepatol Caly 18 353 1993 10.1016/S0168-8278(05)80280-6 A prospective study of bacterial infections in patients with cirrhosis 

  5. Hepatology Felisart 5 457 1985 10.1002/hep.1840050319 Cefotaxime is more effective than ampicillin-tobramycin in cirrhotics with severe infections 

  6. Hepatology Rimola 21 674 1995 10.1002/hep.1840210312 Two different dosages of cefotaxime in the treatment of spontaneous bacterial peritonitis in cirrhosis: results of a prospective, randomized, multicenter study 

  7. Gastroenterology Runyon 100 1737 1991 10.1016/0016-5085(91)90677-D Short course vs long-course antibiotic treatment of spontaneous bacterial peritonitis. A randomized controlled study in 100 patients 

  8. Chemotherapy Mercader 35 suppl 2 23 1989 10.1159/000238735 Use of ceftriaxone in the treatment of bacterial infections in cirrhotic patients 

  9. Antimicrob Agents Chemother Gomez-Jimenez 37 1587 1993 10.1128/AAC.37.8.1587 Randomized trial comparing ceftriaxone with cefonicid for treatment of spontaneous bacterial peritonitis in cirrhotic patients 

  10. Hepatology Grange 11 334 1991 Amoxicillin-clavulanic acid therapy of spontaneus bacterial peritonitis: A prospective study of twenty-seven cases in cirrhotic patients 

  11. Gastroenterology Navasa 111 1011 1996 10.1016/S0016-5085(96)70069-0 Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis 

  12. Controlled Clinical Trials Blackwelder 3 345 1982 10.1016/0197-2456(82)90024-1 “Proving the null hypothesis” in clinical trials 

  13. Ann Intern Med Conn 60 568 1964 10.7326/0003-4819-60-4-568 Spontaneous peritonitis and bacteriemia in Laennec's cirrhosis caused by enteric organisms. A relatively common but rarely recognized syndrome 

  14. Rev Clin Esp Sanchez-Tapias 123 375 1971 Infeccion peritoneal en la cirrosis hepatica con ascitis 

  15. Medicine Conn 50 161 1971 10.1097/00005792-197105000-00002 Spontaneous bacterial peritonitis in cirrhosis: variation on a theme 

  16. Med Clin North Am Correia 59 963 1975 10.1016/S0025-7125(16)31995-2 Spontaneous bacterial peritonitis in cirrhosis: endemic or epidemic? 

  17. Hepatology Tito L Rimola 8 27 1988 10.1002/hep.1840080107 Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors 

  18. Dig Dis Sci Terg 37 1499 1992 10.1007/BF01296493 Analysis of clinical course and prognosis of culture-positive spontaneous bacterial peritonitis and neutrocytic ascites 

  19. Gastroenterol Clin Biol Silvain 13 335 1989 Les septicemies et les infections du liquide d'ascite du cirrhotique: peuvent-elles etre traitees exclusivement par voie orale? 

  20. Antimicrob Agents Chemother Cornaglia 31 1651 1987 10.1128/AAC.31.10.1651 In vitro activity of ciprofloxacin against aerobic bacteria isolated in a Southern European Hospital 

  21. Eur J Clin Microbiol Bergan 5 187 1986 10.1007/BF02013984 Pharmacokinetics of ciprofloxacin and increasing oral doses 

  22. Antimicrob Agents Chemother Drusano 30 444 1986 10.1128/AAC.30.3.444 Absolute oral bioavailability of ciprofloxacin 

  23. Antimicrob Agents Chemother Plaisance 31 956 1987 10.1128/AAC.31.6.956 Effect of dose size on bioavailability of ciprofloxacin 

  24. Am J Med Ramirez-Ronda 82 Suppl. 4 A 220 1987 Comparative, double-blind study of oral ciprofloxacin and intravenous cefotaxime in skin and skin structure infections 

  25. Am J Med Parish 82 Suppl. 4 A 227 1987 Systemic treatment of cutaneous infection a comparative study of ciprofloxacin and cefotaxime 

  26. Am J Med Self 82 Suppl. 4 A 239 1987 Use of ciprofloxacin in the treatment of serious skin and skin structure infections 

  27. Am J Med Perez-Ruvalcaba 82 Suppl. 4 A 242 1987 Double-blind comparison of ciprofloxacin and cefotaxime in the treatment of skin and skin structure infection 

  28. Hepatology Toledo 17 251 1993 10.1002/hep.1840170215 Spontaneous bacterial peritonitis in cirrhosis: predictive factors of infection resolution and survival in patients treated with cefotaxime 

  29. Gastroenterology 111 1147 1996 10.1016/S0016-5085(96)70087-2 Guadalupe Garcia Tsao. Treatment of spontaneous bacterial peritonitis with oral ofloxacin: inpatient or outpatient therapy? 

  30. Am J Med Weinstein 64 592 1978 10.1016/0002-9343(78)90578-8 Spontaneous bacterial peritonitis: a review of 28 cases with emphasis on improved survival and factors influencing prognosis 

  31. Gastroenterol Clin Biol Ink 13 556 1989 Pronostic de l'infection spontanee d'ascite chez le cirrhotique 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로